Trainings By Informa Markets

Nitrosamine Impurities in API and Pharmaceutical Products – How to Deal?

Duration - 30 Minutes

About the course

The recent recall of Ranitidine by FDA has raised serious global concerns with respect to testing and quality of pharmaceutical products. In the past, NDMA and NDEA impurities were also reported in valsartan and sartans resulting in product recall by FDA and EMA. This presentation will deliberate on ways to deal with these impurities in drug substances and drug products.

Speaker Profile

Dr. BM Rao

VP & Head – Analytical Science & Technology & CQC
Dr. Reddys Laboratories

Website by: Xpoteck